CC Small or few human trials. Promising, not proven. How we grade →Randomized controlled trial · 300 adults with newly found high blood sugar
Effectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: a multi-center, double-blind, randomized, parallel-controlled study
J Ming, X Yu, X Xu, et al. Genome Medicine. 2021.
- In plain language
- Berberine 500 mg twice a day for 16 weeks lowered fasting glucose 0.50 mmol/L more than placebo; HbA1c fell clearly only with berberine plus Bifidobacterium.
- Limits
- Mild high blood sugar at baseline (HbA1c near 6.2%); retrospectively registered; drug makers supplied products and three authors were affiliated with a company research institute.
- Which of our grades it feeds
- CC Small or few human trials. Promising, not proven. How we grade →Science summary: Berberine and glucose metabolism
- Source
- doi.org/10.1186/s13073-021-00942-7 · PubMed 34365978 · Free full text
Summary written by Everstack from the published abstract. Verified against Crossref on 2026-10-15. The authors do not endorse Everstack. We sell some of what we grade.